Cancer News and Research

Latest Cancer News and Research

Alliance HealthCare Services third quarter 2013 revenue decreases $2.6 million

Alliance HealthCare Services third quarter 2013 revenue decreases $2.6 million

IPHI receives grants to increase awareness of health-care service delivery and related policy issues

IPHI receives grants to increase awareness of health-care service delivery and related policy issues

Advanced prostate cancer therapies: an interview with Dr. Nancy Dawson, Lombardi Comprehensive Cancer Center

Advanced prostate cancer therapies: an interview with Dr. Nancy Dawson, Lombardi Comprehensive Cancer Center

Depression alert in Asian COPD patients

Depression alert in Asian COPD patients

PDL BioPharma closes financing transaction with Durata Therapeutics

PDL BioPharma closes financing transaction with Durata Therapeutics

PhotoMedex third quarter 2013 revenues decrease 19% to $45.9 million

PhotoMedex third quarter 2013 revenues decrease 19% to $45.9 million

Finding challenges assumption that bisexual men responsible for HIV transmission to female partners

Finding challenges assumption that bisexual men responsible for HIV transmission to female partners

Colorectal cancer screening rates remain too low, reveals new Vital Signs report

Colorectal cancer screening rates remain too low, reveals new Vital Signs report

New drug combination therapy effectively kills cancer cells

New drug combination therapy effectively kills cancer cells

ADC Therapeutics, Five Prime sign exclusive license agreement for human antibodies

ADC Therapeutics, Five Prime sign exclusive license agreement for human antibodies

AMGA honors Mid-Atlantic Permanente Medical Group with Acclaim Award

AMGA honors Mid-Atlantic Permanente Medical Group with Acclaim Award

Web-based, at-home interventions help mothers address behaviors to protect against childhood obesity

Web-based, at-home interventions help mothers address behaviors to protect against childhood obesity

ImmunoGen starts clinical testing with its EGFR-targeting ADC, IMGN289 for several types of cancers

ImmunoGen starts clinical testing with its EGFR-targeting ADC, IMGN289 for several types of cancers

Physicians' Education Resource to host 11th Annual School of Breast Oncology in Atlanta, GA

Physicians' Education Resource to host 11th Annual School of Breast Oncology in Atlanta, GA

Imaginative play with medically themed toys may improve recovery in chronically ill children

Imaginative play with medically themed toys may improve recovery in chronically ill children

ImmunoGen decides to stop IMGN901 Phase II SCLC study

ImmunoGen decides to stop IMGN901 Phase II SCLC study

Scientists investigate combined action of two different compounds against CML

Scientists investigate combined action of two different compounds against CML

Researchers use machine learning approach to accurately diagnose breast cancer

Researchers use machine learning approach to accurately diagnose breast cancer

Study: Interactions between inflammation and changes in gut microbiota may result in colon tumors

Study: Interactions between inflammation and changes in gut microbiota may result in colon tumors

Bioniche Life Sciences announces financial results for first quarter of Fiscal 2014

Bioniche Life Sciences announces financial results for first quarter of Fiscal 2014

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.